Stock SAVA CASSAVA SCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Cassava Sciences, Inc.

Equities

SAVA

US14817C1071

Market Closed - Nasdaq
Other stock markets
 01:30:00 07/06/2024 am IST 		5-day change 1st Jan Change
19.94 USD -3.58% Intraday chart for Cassava Sciences, Inc. -11.18% -11.42%
17/05 HC Wainwright Adjusts Price Target on Cassava Sciences to $131 From $124, Maintains Buy Rating MT
10/05 Cassava Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
CASSAVA SCIENCES, INC. Stock Cassava Sciences, Inc.
 992M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 125B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 109B
BIONTECH SE Stock BioNTech SE
 24.74B -
ARGENX SE Stock argenx SE
 22.67B -
GENMAB A/S Stock Genmab A/S
 18.14B
  1. Stock Market
  2. Equities
  3. SAVA Stock
  4. Charts Cassava Sciences, Inc.
  5. Sector Chart